Zacks Small Cap Research provides equity research on #smallcap and #microcap firms. bit.ly/scr_disc

Chicago IL
Reflecting $SWP.TO Swiss Water’s optimistic outlook, the company filed notice of intention to launch a Normal Course Issuer Bid (NCIB) to repurchase its shares. #ConsumerTrends #BeverageIndustry buff.ly/UJbMzF2
132
$RERE Secondary Smartphone Market Remains Resilient Amid Industry Headwinds #recycling #preowned buff.ly/4XGuKMZ
138
$AMS is focused on strengthening its balance sheet; believe insider liquidity in extension supports positive outlook #healthcare #technology buff.ly/XkuK7b8
169
$HITI: High Tide Continues to Outperform Canadian Cannabis Industry #CannabisRetailGrowth #CannabisStocks buff.ly/TNVN9rq
3
278
$IXRRF Ionic Rare Earths’ Outlook Is for Strong, Profitable Growth as Commercial Operations Commence at the Belfast Recycling Plant in 2028 #rareearthoxides #smallcaps buff.ly/xON1pa3
247
Zacks SCR retweeted
20+ years average analyst experience. 100+ small-cap companies covered. $0 cost to you. Sign up for free alerts: buff.ly/i9QPmaV #SmallCapInvesting #StockResearch
1
291
$CING Distribution Deal with Prasco Signed #smallcaps #biopharma buff.ly/bRb8PJk
192
$GXAI Strong Q2 Top-Line Beat, Gaming Asset Sale, and Raised 2026 Outlook Offset by Dilution Risks #GenerativeAI #TechGrowth buff.ly/Q0J30E9
185
$BSIN Big Sky Industrial Updates Business Developments for Montana Properties and Announces 2nd Quarter 2026 Results #MarketExpansion #SustainableEnergy buff.ly/sBNqkNy
209
$RVPH Patent Filed for New Brilaroxazine Formulation #NeuroInnovation #BioTech buff.ly/tINzsSt
189
$ABEO NTAP Status for Zevaskyn Starting Oct. 1, 2026 #biotech #genetherapy buff.ly/zJsfh1c
229
$BBLG in Good Position as Trials Progress #backpain #medtech buff.ly/OU9NLbv
229
$KBSX FST Corp Reports Solid 2nd Quarter 2026 Financial Results #SportsTech #PerformanceGolf buff.ly/qNkf03c
201
$CTSO CytoSorbents Expects to File a New De Novo Application for DrugSorb-ATR in early 2027 #medtech #immunotherapy buff.ly/r68FsDt
220
$IMNN Increased Enrollment Rate for OVATION 3 Trial #vaccines #DNA buff.ly/onq2R1n
1
253